Literature DB >> 12491633

[Multiple endocrine neoplasia type I or Werner syndrome. What is important to know about surgery of a rate disease].

P Goudet1, A Calender, P Cougard, A Murat, J F Henry, J L Kraimps, G Cadiot, J L Peix, E Sarfati, M Mignon, C Proye.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is a rare but misleading disease. The diagnosis is evocated when two main lesions are present (parathyroid, endocrine pancreas, pituary gland) but also when a family tree shows recurrent lesions. Other lesions must be taken into account (adrenal glands, neuroendocrine thymic or bronchic lesions, cutaneous lesions, lipomas, nervous central system tumors). Any surgical cure without knowing the MEN1 background leads to failure. Specific treatment of each lesion is reviewed. Genetic diagnosis is possible but the mutation is not found in all cases. Nevertheless, when the mutation is known in a family, a negative genetic test allows to exclude the disease. Prognosis is related to hepatic metastases and to thymic neuroendocrine tumors which are rare (2.1%) but aggressive. As a general rule, any apparently isolated endocrine lesion such hyperparathyroidism must prompt the surgeon to look for another endocrine lesion and to look for an abnormal family tree with recurent monoglandular or pluriglandular lesions.

Entities:  

Mesh:

Year:  2002        PMID: 12491633     DOI: 10.1016/s0003-3944(02)00848-9

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  2 in total

1.  Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas.

Authors:  Frederic Triponez; David Dosseh; Pierre Goudet; Patrick Cougard; Catherine Bauters; Arnaud Murat; Guillaume Cadiot; Patricia Niccoli-Sire; Jean-Alain Chayvialle; Alain Calender; Charles A G Proye
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  [Multiple endocrine neoplasia type 1: about a case].

Authors:  Gladys Anguezomo; Ghizlane El Mghari; Nawal El Ansari
Journal:  Pan Afr Med J       Date:  2019-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.